Search results
TikTok to restrict weight loss drug promotion (NYSE:NVO)
Seeking Alpha· 1 hour agoThe restrictions taking effect on May 17 will also apply to content related to anabolic steroids, a...
Edgewise's sevasemten earns EU orphan drug status By Investing.com
Investing.com· 3 hours agoEdgewise Therapeutics, Inc. (NASDAQ:EWTX), a biopharmaceutical company focused on muscle diseases,...
Must Read: Ganni Names New CEO, Cécred x BeyGood Fund Announces First Grant Winners
Fashionista via Yahoo News· 12 minutes agoGonzalez, her handbag company Gzuniga and associate Mauricio Giraldo pled guilty in November, and...
Novartis raises forecasts as top drug sales beat Wall Street estimates
BioPharma Dive via Yahoo Finance· 5 hours agoNovartis is only six months removed from spinning out its generic drug unit Sandoz into a standalone...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 3 hours agoThe upfront cash and CV payment add up to a total transaction value of approximately $2.4 billion....
No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win
Investor's Business Daily· 55 minutes agoTop-notch biotech stock Neurocrine Biosciences launched higher Tuesday after the company's Takeda...
Edgewise gets EU orphan drug status for muscular dystrophy drug (NASDAQ:EWTX)
Seeking Alpha· 2 hours agoEdgewise Therapeutics (EWTX) has received orphan drug designation from EU regulators for sevasemten...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 3 hours agoEqually important to discuss is the company's debt, which skyrocketed in 2018 due to its $62 billion acquisition of Shire. The goals of this deal were...
Oncologists' meetings with drug reps don't help cancer patients live longer
WUSF 89.7· 1 day agoPharmaceutical company reps have been visiting doctors for decades to tell them about the latest...
Alzheimer's drug embrace slows down as US doctors' reluctance grows
Fox News· 2 hours agoNine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai...
